CGP-79807
CGP-79807 is a potent CDC2 protein kinase inhibitor that originated by Novartis. In Sep 2000, Preclinical development for Cancer in Switzerland was on-going, but no development has been reported.
| Supplier | BOC Sciences |
|---|---|
| Product # | 1229665-91-1 |
| Pricing | Inquire |
| Cas | 1229665-91-1 |
| Molecular Weight | 370.44 |
| Molecular Formula | C20H23N7O |
| Canonical SMILES | CCn1c2nc(nc(c2nc1)Nc3cc(ccc3)C#N)N[C@H]4CC[C@@H](CC4)O |